Reaction to gold therapy.

Reaction to gold therapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Reaction to gold therapy. Abstract Text:

Reaction to gold therapy. Publishing Authors By Initials

For similar fluids and secretions: bodily secretions: sweat research abstracts see: fluids and secretions: bodily secretions: sweat research

PUBMED ID PMID:

MEDLINE DATE:

Reaction to gold therapy. Journal Published:

PUBLICATION TYPE: Letter

Journal: Archives of dermatology

VOLUME: 115

Page Numbers: 112

Journal Abbreviation: Arch Dermatol

ISSN: 0003-987X

DAY: 17

MONTH: Jan

YEAR: 1979

Reaction to gold therapy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372433

Reaction to gold therapy. Keywords Mesh Terms:

KEYWORDS: Sweat

MESH TERMS: metabolism

Chemical & Substance for Abstract: Reaction to gold therapy. Information

Substance Name: Gold

Registry Number: 7440-57-5

Grant and Affiliation Information for Reaction to gold therapy.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Reaction to gold therapy Related Publications

• Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease.
• CYCLOPROPANE.
• Cigarette smoking: a child's guide to addiction.
• Criteria for a standard thromboplastin preparation.
• Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
• Glittering with gold therapy.
• Proposed specification for a reference thromboplastin preparation for the control of anticoagulant therapy using coumarin type drugs.
• Reaction to gold therapy.
• Second report on the standardisation of the one-stage prothrombin time for the control of anticoagulant therapy.
• Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis.
• Standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
• The establishment and operation of a Nerve Block Clinic; one year's experience at the Los Angeles County Hospital.
• The simplified two-stage assay for Factor 8 using a combined reagent.
• Third report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
• Thromboplastin reference preparations.
• Tumour necrosis factor alpha blockade induces an anti-inflammatory growth hormone signalling pathway in experimental colitis.